2013
Bevacizumab: Finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary hemorrhagic telangiectasia
Young LH, Henderson KJ, White RI, Garcia‐Tsao G. Bevacizumab: Finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary hemorrhagic telangiectasia. Hepatology 2013, 58: 442-445. PMID: 23686865, DOI: 10.1002/hep.26472.Commentaries, Editorials and Letters
2008
Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: In search of predictors of significant disease
Garcia‐Tsao G, Swanson KL. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: In search of predictors of significant disease. Hepatology 2008, 48: 1377-1379. PMID: 18972437, DOI: 10.1002/hep.22672.Peer-Reviewed Original ResearchArteriovenous MalformationsHumansLiverLiver CirculationPrevalenceTelangiectasia, Hereditary HemorrhagicUltrasonography